Rani Therapeutics Holdings (RANI) Invested Capital (2020 - 2025)

Rani Therapeutics Holdings has reported Invested Capital for 6 years, with the latest figure at $41.5 million in Q4 2025.

• On a quarterly basis, Invested Capital rose 47.7% year-over-year to $41.5 million in Q4 2025; TTM through Dec 2025 was $41.5 million, a 47.7% increase from a year earlier, with the FY2025 full-year figure at $41.5 million, up 47.7% from the prior year.
• Invested Capital was $41.5 million for Q4 2025 at Rani Therapeutics Holdings, up from $1.6 million in the prior quarter.
• The five-year high for Invested Capital was $132.0 million in Q3 2021, with the low at -$118.9 million in Q2 2021.
• Average Invested Capital over 5 years is $54.9 million, with a median of $54.8 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2025: Invested Capital soared 211.21% in 2021, then tumbled 95.41% in 2025.
• Over 5 years, Invested Capital stood at $121.7 million in 2021, then retreated by 15.19% to $103.2 million in 2022, then plunged by 46.88% to $54.8 million in 2023, then plunged by 48.73% to $28.1 million in 2024, then jumped by 47.7% to $41.5 million in 2025.
• The last three Invested Capital figures came in at $41.5 million (Q4 2025), $1.6 million (Q3 2025), and $8.1 million (Q2 2025), per Business Quant data.